Vanda Pharmaceuticals (VNDA) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -150.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -150.22% |
| Dec 31, 2025 | -179.85% |
| Sep 30, 2025 | -102.74% |
| Jun 30, 2025 | -123.74% |
| Mar 31, 2025 | -65.65% |
| Dec 31, 2024 | -40.10% |
| Sep 30, 2024 | -38.26% |
| Jun 30, 2024 | -35.19% |
| Mar 31, 2024 | -35.11% |
| Dec 31, 2023 | -32.64% |
| Sep 30, 2023 | -72.13% |
| Jun 30, 2023 | -42.76% |
| Mar 31, 2023 | 81.71% |
| Dec 31, 2022 | 14.47% |
| Sep 30, 2022 | -68.05% |
| Jun 30, 2022 | -38.02% |
| Mar 31, 2022 | -122.40% |
| Dec 31, 2021 | -14.20% |
| Sep 30, 2021 | 2.50% |
| Jun 30, 2021 | 23.61% |
| Mar 31, 2021 | 35.72% |
| Dec 31, 2020 | 79.15% |
| Sep 30, 2020 | 45.81% |
| Jun 30, 2020 | 94.28% |
| Mar 31, 2020 | 27.22% |
| Dec 31, 2019 | 107.64% |
| Dec 31, 2018 | 36.42% |
| Dec 31, 2017 | -26.46% |
| Sep 30, 2017 | -35.72% |
| Jun 30, 2017 | 63.94% |
| Mar 31, 2017 | 40.08% |
| Dec 31, 2016 | 63.15% |
| Dec 31, 2015 | -15.29% |
| Dec 31, 2014 | 121.38% |
| Sep 30, 2014 | 28.62% |
| Jun 30, 2014 | -133.92% |
| Mar 31, 2014 | -454.06% |
| Dec 31, 2013 | -74.19% |
| Sep 30, 2013 | -52.48% |
| Jun 30, 2013 | -68.10% |